{"database": "lobbying", "table": "lobbying_activities", "rows": [[2307206, "7a4307b4-b8f5-4e35-be19-216455ee40d9", "Q2", "ALLERGAN USA, INC.", 63837, "ALLERGAN USA, INC.", 2019, "second_quarter", "CPT", "Proposals to enhance intellectual property protections to meet unmet medical needs, notably research and development of life-saving therapies; proposals to modify the Food Drug and Cosmetic Act which simplify pathways to approve patent claims.", "Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", null, 1060000, 0, 0, "2019-07-17T13:16:00.050000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2307206"], "units": {}, "query_ms": 24.97479401063174, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}